David Needle
| David Needle | |
| Occupation | Veterinary pathologist |
|---|---|
| Employer | University of New Hampshire |
David Needle is a veterinary pathologist at the University of New Hampshire in Durham, New Hampshire, where he works at the NH Veterinary Diagnostic Laboratory.[1] His research has covered the population genomics of Staphylococcus pseudintermedius in companion animals and the distribution of antibiotic resistance and virulence genes in Staphylococcus aureus across animal hosts.[2]
Career
Needle has held the role of veterinary pathologist at the NH Veterinary Diagnostic Laboratory, part of the University of New Hampshire, since 2015.[3]
Research
According to Semantic Scholar, Needle has published 40 papers that have been cited a total of 692 times, giving an h-index of 14.[4]
His work has included a population genomics study of Staphylococcus pseudintermedius in companion animals in the United States, published in Communications Biology and cited 51 times, and a study of shared antibiotic resistance and virulence genes in Staphylococcus aureus from diverse animal hosts, published in Scientific Reports and cited 48 times.[5] He has also published on the accessory genome dynamics of local and global Staphylococcus pseudintermedius populations in Frontiers in Microbiology, cited 19 times.[6]
Other published work attributed to Needle includes a case report on fatal bronchopneumonia caused by skunk adenovirus 1 in an African pygmy hedgehog in the Journal of Veterinary Diagnostic Investigation, cited 18 times, and a case series on glaucoma associated with uveal cysts and goniodysgenesis in American Bulldogs in Veterinary Ophthalmology, also cited 18 times.[7]
According to National Science Foundation records, Needle is associated with a $5,999,362 award at the University of New Hampshire titled "E-RISE: EMBEDDEd-NH: Endeavor for Multi-omics-Based Exploration, Data-Driven modeling, and Education in NH," with a start date of July 16, 2026.[8]
Selected publications
- "The Carbonic Anhydrase Inhibitor Ethoxzolamide Inhibits the Mycobacterium tuberculosis PhoPR Regulon and Esx-1 Secretion and Attenuates Virulence," Antimicrobial Agents and Chemotherapy (2015)[9]
- "Population genomics of Staphylococcus pseudintermedius in companion animals in the United States," Communications Biology (2020)[10]
- "Shared antibiotic resistance and virulence genes in Staphylococcus aureus from diverse animal hosts," Scientific Reports (2022)[11]
- "Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia," Blood Advances (2019)[12]
- "Polysorbates prevent biofilm formation and pathogenesis of Escherichia coli O104:H4," Biofouling (2016)[13]
- "Accessory Genome Dynamics of Local and Global Staphylococcus pseudintermedius Populations," Frontiers in Microbiology (2022)[14]
- "Fatal bronchopneumonia caused by skunk adenovirus 1 in an African pygmy hedgehog," Journal of Veterinary Diagnostic Investigation (2018)[15]
- "Glaucoma associated with uveal cysts and goniodysgenesis in American Bulldogs: a case series," Veterinary Ophthalmology (2013)[16]
External links
- ↑ ORCID record for David Needle, ORCID iD 0000-0002-7215-5306.
- ↑ Semantic Scholar profile for David Needle.
- ↑ ORCID record for David Needle, ORCID iD 0000-0002-7215-5306.
- ↑ Semantic Scholar profile for David Needle.
- ↑ Semantic Scholar profile for David Needle.
- ↑ Semantic Scholar profile for David Needle.
- ↑ Semantic Scholar profile for David Needle.
- ↑ National Science Foundation award records.
- ↑ Semantic Scholar profile for David Needle.
- ↑ Semantic Scholar profile for David Needle.
- ↑ Semantic Scholar profile for David Needle.
- ↑ Semantic Scholar profile for David Needle.
- ↑ Semantic Scholar profile for David Needle.
- ↑ Semantic Scholar profile for David Needle.
- ↑ Semantic Scholar profile for David Needle.
- ↑ Semantic Scholar profile for David Needle.